Month: July 2024

UW Program for Advanced Cell Therapy has an open position for a Regulatory Scientist. Join a dynamic team led by Jacques Galipeau pushing forward innovative cell therapies for cancer survivors and other disorders. Interested candidates …

On July 2 2024 FDA CBER approved the PACT-sponsored Investigational Device Exemption (IDE) application # 30707 named “Allogeneic, TCR αβ and CD19+ cell-depleted peripheral blood mononuclear cells”. Allogeneic BMT patients receiving post-transplant cyclophosphamide to reduce risk …